我要投票 曲焕章在中医保健行业中的票数:559
· 外 推 电 报 ·
2026-01-09 08:41:24 星期五

【曲焕章是哪个国家的品牌?】

曲焕章是什么牌子?「曲焕章」是 昆明曲焕章药业开发有限公司 旗下著名品牌。该品牌发源于云南省昆明市,由创始人陈华在2003-11-25期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力曲焕章品牌出海!将品牌入驻外推网,定制曲焕章品牌推广信息,可以显著提高曲焕章产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

昆明曲焕章药业由曲焕章孙子陈晓静、陈小弟于2003年注册成立,同年在香港亦注册成立曲焕章药业,取名“云南曲焕章大药房药业(香港)有限公司,2004年7月28日更名为云南曲焕章药业(香港)有限公司。

曲焕章先生1880年生,是中国民国时期中医,集中医药与民族医药之大成,于1902年发明试制成功“万应百宝丹”(后来的云南白药),后又陆续研制成“虎力散”“撑骨散”等共22种功效号的中药。在抗日战争,解放战争等关系中国命运转折的事件中屡著奇效,救人无数,得到海内外一致赞誉。

先生于1938年在重庆逝世。

1956年2月,全国解放后,曲焕章遗孀缪兰英把白药秘方献给了新中国,由昆明制药厂生产,并且将曲氏白药更名为 云南白药 。后将22味密方传承给其女曲竹林女士,曲竹林女士于2002年传承给其子陈晓静、陈小弟。2015年陈晓静,陈小弟正式向昆明曲焕章药业开发有限公司移交曲焕章秘方。

2018年7月公司入驻昆明高新技术产业开发区,2018年9月公司与地产名企远洋控股集团(中国)有限公司携手在昆明签署协议,共同兴建以“医药研发、教育培养、医养结合、健康休闲”为主题的云南的“曲焕章名族医药产业园”,同年开办中药饮片厂,建立中药饮片GMP生产车间。

昆明曲焕章药业开发有限公司主营业务包括:

1、中药和民族药创新药研究、开发;

2、化学药和生物制品的仿制药和创新药研究、开发;

3、营养保健食品研究、开发和销售;

4、中药饮片生产、销售。

昆明曲焕章药业开发有限公司将“曲焕章”中药组方加以传承,利用现代制药工艺加以创新,秉承开放务实、兼收并蓄、执着创新的精神,专注于在满足消费者健康、养生需求的基础上,打造具有“高科技含量,高文化附加值,高市场竞争力”的大健康产业,再续新时代“曲焕章”的新辉煌。


英文翻译:Kunming quhuanzhang Pharmaceutical Co., Ltd. was registered and established in 2003 by Chen Xiaojing and Chen Xiaodi, grandsons of quhuanzhang. In the same year, quhuanzhang Pharmaceutical Co., Ltd. was also registered and established in Hong Kong. It was named "Yunnan quhuanzhang pharmacy pharmaceutical (Hong Kong) Co., Ltd. and renamed as Yunnan quhuanzhang Pharmaceutical (Hong Kong) Co., Ltd. on July 28, 2004. Mr. Qu Huanzhang, born in 1880, is a great achievement of traditional Chinese medicine in the period of the Republic of China, focusing on medicine and national medicine. In 1902, he successfully invented and trial produced "WANYING baibaodan" (later Yunnan Baiyao). Later, he successively developed 22 kinds of Chinese medicine, including "Huli powder" and "zhengu powder". In the Anti Japanese War, the war of liberation and other events related to China's fate, it has repeatedly achieved miraculous results, saved countless people and won unanimous praise at home and abroad. Mr. Chen died in Chongqing in 1938. In February 1956, after the national liberation, Miao Lanying, the widow of Qu Huanzhang, dedicated the secret recipe of white medicine to new China, which was produced by Kunming Pharmaceutical Factory, and renamed Qu's white medicine Yunnan white medicine. After that, 22 Weimi Fang was passed on to Ms. Zhulin, a female opera, and MS. quzhulin was passed on to her sons Chen Xiaojing and Chen Xiaodi in 2002. In 2015, Chen Xiaojing and Chen Xiaodi formally handed over quhuanzhang secret recipe to Kunming quhuanzhang Pharmaceutical Development Co., Ltd. In July 2018, the company settled in Kunming high tech Industrial Development Zone. In September 2018, the company signed an agreement with Yuanyang holding group (China) Co., Ltd., a famous real estate enterprise, to jointly build "quhuanzhang Mingzu Pharmaceutical Industrial Park" in Yunnan with the theme of "medical research and development, education and training, combination of medical and nursing, health and leisure". In the same year, the company opened a herbal medicine factory and established herbal medicine pieces GMP production workshop. The main business of Kunming quhuanzhang Pharmaceutical Development Co., Ltd. includes: 1. Research and development of innovative drugs of traditional Chinese medicine and ethnic medicine; 2. Research and development of generic and innovative drugs of chemical and biological products; 3. Research, development and sales of nutrition and health food; 4. Production and sales of Chinese herbal pieces. Kunming quhuanzhang Pharmaceutical Development Co., Ltd. inherits "quhuanzhang" traditional Chinese medicine formula, innovates with modern pharmaceutical technology, adheres to the spirit of openness, pragmatism, inclusiveness and persistent innovation, and focuses on building a large health industry with "high-tech content, high cultural added value and high market competitiveness" on the basis of satisfying consumers' health and health care needs The new brilliance of "Qu Huanzhang" in the new era.

本文链接: https://www.waitui.com/brand/4c7673c46.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

华纳兄弟探索公司拒绝派拉蒙,坚持与Netflix的交易

华纳兄弟探索公司敦促股东拒绝派拉蒙的敌意收购,并重申其将工作室和流媒体资产出售给Netflix的协议是更优报价,且完成路径更明确。(新浪财经)

42分钟前

Grok因涉性图像面临审查

埃隆·马斯克麾下未上市企业xAI在其Grok模型被用于生成涉性图像(包括未成年人图像)后受到抨击,这引发了监管机构对该与X平台集成的工具的调查和政策质疑。(新浪财经)

42分钟前

保险公司发债规模连续三年超千亿元,多重因素推动

连续三年,保险公司发行债券规模超千亿元。刚刚过去的2025年,23家保险公司发债规模合计达1042亿元。业内人士普遍认为,这背后有多重推动因素——低利率周期下,保险公司普遍面临较高的资本补充需求;利率下行,发债成本更低,险企有动力发新债置换旧债;也有险企希望在利率低位时融资以进一步夯实资本实力、增厚发展安全垫。另外,在逆周期监管思路下,保险公司发债也在一定程度上获得了监管部门的支持。(证券时报)

42分钟前

中信建投:白酒板块迎来周期底部配置机会

36氪获悉,中信建投指出,白酒产业“五底阶段”(政策底、库存底、动销底、批价底、产销底)与资本市场“三低一高”(预期低、估值低、公募持仓低、高分红)共振,结合近期市场策略相继落地,站在春节旺季来临之际,认为本轮白酒调整期拐点将至,资本市场预期先行,白酒板块迎来周期底部配置机会。

42分钟前

CrowdStrike以7.4亿美元收购身份安全初创公司SGNL

网络安全提供商CrowdStrike周四宣布,将以近7.4亿美元的价格收购身份管理初创公司SGNL,以在人工智能网络攻击时代加强防御。该公司表示,此次收购将帮助CrowdStrike的Falcon云安全平台用户更好地管理人员和人工智能身份访问请求以及实时风险。该交易预计将于2027财年第一季度完成。(新浪财经)

42分钟前

本页详细列出关于曲焕章的品牌信息,含品牌所属公司介绍,曲焕章所处行业的品牌地位及优势。
咨询